ABOUT CELYAD ONCOLOGY
Celyad Oncology is a biotechnology company focused on the research and discovery of chimeric antigen receptor (CAR) T-cell therapies for cancer.
At Celyad Oncology, we are pursuing next-generation cellular immunotherapies by applying our broad understanding of immunology, novel technology platforms and modular design approach to drug discovery.
Novel CAR T-cell Immunotherapies
Advancing both allogeneic and autologous CAR T-cell therapy candidates for the treatment of cancer
Stay informed about the latest news!
Sign up FOR our newsletter